idemia, diabetes, and other atherosclerotic
risk factors. A statin and ACE inhibitor should be considered, given the broad potential beneﬁts to cardiovascular disease and acceptable safety proﬁle. Insufﬁcient
data currently exist to recommend use of doxycycline
or roxithromycin. Patients should be counseled that
moderate physical activity does not precipitate rupture
or inﬂuence AAA growth rate.41,29